HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mauro Zaccarelli Selected Research

Fatigue

5/2003Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mauro Zaccarelli Research Topics

Disease

8Infections
05/2021 - 11/2004
6Disease Progression
09/2013 - 11/2004
5Acquired Immunodeficiency Syndrome (AIDS)
01/2010 - 02/2004
4Viremia
05/2021 - 09/2015
4Hepatitis C
10/2019 - 11/2004
4HIV Infections (HIV Infection)
01/2018 - 02/2004
3Hypersensitivity (Allergy)
01/2014 - 05/2010
2Coinfection
05/2021 - 01/2017
2Neoplasms (Cancer)
01/2020 - 09/2013
2Lipodystrophy
11/2012 - 05/2005
1Respiratory Insufficiency (Respiratory Failure)
04/2021
1COVID-19
04/2021
1Reinfection
01/2021
1Virus Diseases (Viral Diseases)
08/2020
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
12/2019
1Erectile Dysfunction
12/2019
1Kaposi Sarcoma (Kaposi's Sarcoma)
10/2019
1Hepatitis
10/2016
1Hepatitis E
10/2016
1Insulin Resistance
01/2016
1Drug-Related Side Effects and Adverse Reactions
07/2014
1Radiodermatitis
09/2013
1Sleep Initiation and Maintenance Disorders (Insomnia)
05/2010
1Opportunistic Infections (Opportunistic Infection)
09/2007
1HIV Seropositivity
11/2004
1Vomiting
05/2003
1Fatigue
05/2003
1Gynecomastia
09/2002

Drug/Important Bio-Agent (IBA)

7RNA (Ribonucleic Acid)IBA
05/2021 - 07/2005
6Pharmaceutical PreparationsIBA
12/2019 - 05/2003
3Antiviral Agents (Antivirals)IBA
05/2021 - 01/2018
3DNA (Deoxyribonucleic Acid)IBA
05/2021 - 09/2015
2sofosbuvir drug combination ledipasvirIBA
10/2019 - 01/2017
2Glucose (Dextrose)FDA LinkGeneric
01/2016 - 11/2012
1fibrin fragment D (D-dimer)IBA
04/2021
1Viral RNAIBA
04/2021
1SteroidsIBA
12/2019
1Cocaine (Cocaine HCl)IBA
12/2019
1AmphetaminesIBA
12/2019
1AcidsIBA
12/2019
1Illicit Drugs (Recreational Drugs)IBA
12/2019
1KetamineFDA LinkGeneric
12/2019
1VaccinesIBA
10/2018
1InterferonsIBA
01/2017
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2017
1Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2017
1Biomarkers (Surrogate Marker)IBA
10/2016
1AntigensIBA
10/2016
1Immunoglobulin M (IgM)IBA
10/2016
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
07/2014
1RacivirIBA
01/2014
1Taxoids (Taxanes)IBA
09/2013
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2013
1LipidsIBA
11/2012
1efavirenz (Sustiva)FDA Link
05/2006
1Lamivudine (Epivir)FDA Link
05/2006
1abacavir (Ziagen)FDA Link
05/2006
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2006
1EnzymesIBA
01/2006
1LDL CholesterolIBA
01/2006
1Protease Inhibitors (Protease Inhibitor)IBA
07/2005
1Atazanavir Sulfate (Reyataz)FDA Link
05/2005

Therapy/Procedure

6Highly Active Antiretroviral Therapy (HAART)
01/2020 - 09/2002
6Therapeutics
10/2019 - 09/2002
1Artificial Respiration (Mechanical Ventilation)
04/2021
1Drug Therapy (Chemotherapy)
09/2013
1Radiotherapy
09/2013
1Aftercare (After-Treatment)
01/2007